US House Republicans and Democrats are frustrated with the measures pharmaceutical manufacturers and pharmacy benefit managers have taken to lower insulin prices and warned them at an April 10 hearing that a more radical solution is needed – and soon.
“What we’re going to do is get together in a bipartisan way and we’re going to work with all of...






